BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37356116)

  • 1. Enablers and inhibitors to the adoption of mHealth apps by patients - A qualitative analysis of German doctors' perspectives.
    Schroeder T; Seaman K; Nguyen A; Gewald H; Georgiou A
    Patient Educ Couns; 2023 Sep; 114():107865. PubMed ID: 37356116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' Attitudes Toward Prescribable mHealth Apps and Implications for Adoption in Germany: Mixed Methods Study.
    Dahlhausen F; Zinner M; Bieske L; Ehlers JP; Boehme P; Fehring L
    JMIR Mhealth Uhealth; 2021 Nov; 9(11):e33012. PubMed ID: 34817385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of General Practitioners Toward Prescription of Mobile Health Apps: Qualitative Study.
    Sarradon-Eck A; Bouchez T; Auroy L; Schuers M; Darmon D
    JMIR Mhealth Uhealth; 2021 Mar; 9(3):e21795. PubMed ID: 33661123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors' Personal Preference and Adoption of Mobile Apps to Communicate with Patients in China: Qualitative Study.
    Chen D; Han W; Yang Y; Pan J
    JMIR Mhealth Uhealth; 2024 Jun; 12():e49040. PubMed ID: 38857491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Acceptance of Prescribed and Fully Reimbursed mHealth Apps in Germany: An UTAUT2-based Online Survey Study.
    Uncovska M; Freitag B; Meister S; Fehring L
    J Med Syst; 2023 Jan; 47(1):14. PubMed ID: 36705853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cities, two stages in transforming society-a mixed methods study comparing doctors' adoption of mobile apps for communication with patients in Hangzhou and Yancheng, China.
    Chen D; Su Z; Gu Z
    Front Public Health; 2024; 12():1320949. PubMed ID: 38375337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mHealth apps design using quality function deployment.
    Barutçu S
    Int J Health Care Qual Assur; 2019 May; 32(4):698-708. PubMed ID: 31111779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rating analysis and BERTopic modeling of consumer versus regulated mHealth app reviews in Germany.
    Uncovska M; Freitag B; Meister S; Fehring L
    NPJ Digit Med; 2023 Jun; 6(1):115. PubMed ID: 37344556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social Determinants of Mobile Health App Adoption - A Qualitative Study of Older Adults' Perceptions in Australia.
    Schroeder T; Seaman K; Nguyen AD; Gewald H; Georgiou A
    Stud Health Technol Inform; 2023 Jun; 304():81-85. PubMed ID: 37347575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions Aimed at Enhancing Health Care Providers' Behavior Toward the Prescription of Mobile Health Apps: Systematic Review.
    Alkhaldi O; McMillan B; Maddah N; Ainsworth J
    JMIR Mhealth Uhealth; 2023 Feb; 11():e43561. PubMed ID: 36848202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path".
    Giebel GD; Abels C; Börchers K; Kampka B; Neusser S; Cissarek HR; Plescher F; Wasem J; Blase N
    Front Health Serv; 2024; 4():1372522. PubMed ID: 38545382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to and Facilitators of the Prescription of mHealth Apps in Australian General Practice: Qualitative Study.
    Byambasuren O; Beller E; Hoffmann T; Glasziou P
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17447. PubMed ID: 32729839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems and Barriers Related to the Use of Digital Health Applications: Scoping Review.
    Giebel GD; Speckemeier C; Abels C; Plescher F; Börchers K; Wasem J; Blase N; Neusser S
    J Med Internet Res; 2023 May; 25():e43808. PubMed ID: 37171838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Health Apps for Patient-Centered Care: Review of United States Rheumatoid Arthritis Apps for Engagement and Activation.
    Cozad MJ; Crum M; Tyson H; Fleming PR; Stratton J; Kennedy AB; Lindley LC; Horner RD
    JMIR Mhealth Uhealth; 2022 Dec; 10(12):e39881. PubMed ID: 36469397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing Behavior and Reasonable Price for Mental Health DiGAs - Results of a Pilot Study.
    Seitz K; Scholtes M; Mueller T
    Stud Health Technol Inform; 2023 May; 301():174-179. PubMed ID: 37172176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mobile apps and their usage in rheumatology].
    Krusche M; Ruffer N; Grahammer M; Knitza J
    Z Rheumatol; 2020 Aug; 79(6):554-561. PubMed ID: 32472178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying an Extended UTAUT2 Model to Explain User Acceptance of Lifestyle and Therapy Mobile Health Apps: Survey Study.
    Schomakers EM; Lidynia C; Vervier LS; Calero Valdez A; Ziefle M
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e27095. PubMed ID: 35040801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Most Suitable App to Support the Self-Management of Hypertension: Systematic Selection Approach and Qualitative Study.
    Alessa T; Hawley M; de Witte L
    JMIR Mhealth Uhealth; 2021 Nov; 9(11):e29207. PubMed ID: 34787586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Influencing Adherence to mHealth Apps for Prevention or Management of Noncommunicable Diseases: Systematic Review.
    Jakob R; Harperink S; Rudolf AM; Fleisch E; Haug S; Mair JL; Salamanca-Sanabria A; Kowatsch T
    J Med Internet Res; 2022 May; 24(5):e35371. PubMed ID: 35612886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mHealth App Prescription in Australian General Practice: Pre-Post Study.
    Byambasuren O; Beller E; Hoffmann T; Glasziou P
    JMIR Mhealth Uhealth; 2020 Jun; 8(6):e16497. PubMed ID: 32478660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.